NKX3-2 and cancer: Understanding the complex interactions between GFPT2, NKX3-2, Caspases, and Bcl-2 family proteins may offer valuable insights into developing strategies to combat paclitaxel resistance in EOC, guiding the creation of novel therapeutic approaches for this challenging cancer.